Drug Type Small molecule drug |
Synonyms ACU D2 |
Target |
Action agonists |
Mechanism SIRT3 agonists(NAD-dependent protein deacetylase sirtuin-3, mitochondrial agonists), Epigenetic drug |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Scleroderma, Systemic | Preclinical | United States | - |





